National

Mexico ex-drug czar to be sentenced over bribes from cartels

Oct 17, 2024

Mexico, October 17: Genaro Garcia Luna, who for several years led Mexico's fight against the country's violent drug trade, is set to be sentenced over his U.S. criminal conviction for accepting bribes from the cartels he was supposed to fight.
Garcia Luna, 56, will be sentenced by U.S. District Judge Brian Cogan in Brooklyn federal court at a hearing starting at 4:30p.m. ET (2030 GMT). He faces a mandatory minimum of 20 years in prison.
Prosecutors say Garcia Luna, Mexico's public security minister from 2006 to 2012, should face life in prison after he was convicted in February 2023 for engaging in a criminal drug enterprise taking part in various conspiracies and making false statements.
They said in a Sept. 19 court filing that Garcia Luna took millions of dollars in bribes from the Sinaloa Cartel once led by Joaquin Guzman Loera, better known as El Chapo, and in exchange shielded its members from arrest and protected its shipments of cocaine.
Garcia Luna's lawyer Cesar de Castro urged Cogan to sentence him to no longer than the mandatory minimum, noting he has already spent nearly five years in jail since his 2019 arrest.
"A sentence of 20 years would represent the approximate length of Mr. Garcia Luna's entire career as a public servant to the Mexican government," de Castro wrote
Guzman is serving a life sentence at a Colorado maximum security prison after being convicted in 2019 on drug charges.
Source: Fijian Broadcasting Corporation

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024